...
【24h】

Key intermediates in the synthesis of enantiopure antagonists at NMDA receptors: a structural study

机译:NMDA受体对映纯拮抗剂合成中的关键中间体:结构研究

获取原文
获取原文并翻译 | 示例

摘要

The two diastereomeric amino acid derivatives 8 (3aS,5R,6aS)-5-tert-butoxycarbonylamino-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-3,5-dicarboxylic acid diethyl ester, its epimer 9 (3aS,5S,6aS), and carboxylic acid 10 obtained by hydrolysis of 9, which are intermediates in the synthesis of novel NMDA receptor antagonists 6 and 7 (Fig. 1), have been characterized by X-ray studies at 293 K for 8 and 10, and at 100 K for 9. The configuration of the carbon binding the 5-tert-butoxycarbonylamino moiety (BOC) determines the different molecular complexity: the chain structure for 8, dimeric for 9, and chain dimers for 10. The pharmacophoric parameters in compound 8 (from which the active 7 is derived) are comparable with those observed for NMDA receptor antagonism, while 9 and 10 do not present the structural features, which match these pharmacophoric characteristics. (C) 2005 Elsevier Ltd. All rights reserved.
机译:两种非对映体氨基酸衍生物8(3aS,5R,6aS)-5-叔丁氧基羰基氨基-4,5,6,6a-四氢-3aH-环戊[d]异恶唑-3,5-二羧酸二乙酯,其差向异构体9(3aS,5S,6aS)和通过水解9得到的羧酸10(它们是合成新型NMDA受体拮抗剂6和7(图1)的中间体)已通过293 K的X射线研究进行了表征对于8和10,对于10 K,对于10 K是9。结合5-叔丁氧羰基氨基部分(BOC)的碳的构型决定了不同的分子复杂性:8的链结构,9的二聚体和10的链二聚体。化合物8(从中衍生出活性成分7)的药效学参数与针对NMDA受体拮抗作用观察到的参数相当,而9和10则不具有与这些药效特性匹配的结构特征。 (C)2005 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号